These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 32307496)
1. Common cancer mutations R175H and R273H drive the p53 DNA-binding domain towards aggregation-prone conformations. Li L; Li X; Tang Y; Lao Z; Lei J; Wei G Phys Chem Chem Phys; 2020 May; 22(17):9225-9232. PubMed ID: 32307496 [TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics study on the inhibition mechanisms of ReACp53 peptide for p53-R175H mutant aggregation. Lei J; Cai M; Shen Y; Lin D; Deng X Phys Chem Chem Phys; 2021 Oct; 23(40):23032-23041. PubMed ID: 34612239 [TBL] [Abstract][Full Text] [Related]
3. Oncogenic R248W mutation induced conformational perturbation of the p53 core domain and the structural protection by proteomimetic amyloid inhibitor ADH-6. Liu Q; Yu Y; Wei G Phys Chem Chem Phys; 2024 Jul; 26(29):20068-20086. PubMed ID: 39007865 [TBL] [Abstract][Full Text] [Related]
4. Differential effect of plakoglobin in restoring the tumor suppressor activities of p53-R273H vs. p53-R175H mutants. Lo CS; Alavi P; Bassey-Archibong B; Jahroudi N; Pasdar M PLoS One; 2024; 19(10):e0306705. PubMed ID: 39361615 [TBL] [Abstract][Full Text] [Related]
5. Aggregation-primed molten globule conformers of the p53 core domain provide potential tools for studying p53C aggregation in cancer. Pedrote MM; de Oliveira GAP; Felix AL; Mota MF; Marques MA; Soares IN; Iqbal A; Norberto DR; Gomes AMO; Gratton E; Cino EA; Silva JL J Biol Chem; 2018 Jul; 293(29):11374-11387. PubMed ID: 29853637 [TBL] [Abstract][Full Text] [Related]
6. Butein inhibits cancer cell growth by rescuing the wild-type thermal stability of mutant p53. Song B; Wang J; Ren Y; Su Y; Geng X; Yang F; Wang H; Zhang J Biomed Pharmacother; 2023 Jul; 163():114773. PubMed ID: 37156116 [TBL] [Abstract][Full Text] [Related]
7. Structure and Function of p53-DNA Complexes with Inactivation and Rescue Mutations: A Molecular Dynamics Simulation Study. Kamaraj B; Bogaerts A PLoS One; 2015; 10(8):e0134638. PubMed ID: 26244575 [TBL] [Abstract][Full Text] [Related]
8. Insights into Allosteric Mechanisms of the Lung-Enriched p53 Mutants V157F and R158L. Lei J; Li X; Cai M; Guo T; Lin D; Deng X; Li Y Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077492 [TBL] [Abstract][Full Text] [Related]
9. Elucidating the Mechanisms of R248Q Mutation-Enhanced p53 Aggregation and Its Inhibition by Resveratrol. Liu Q; Li L; Yu Y; Wei G J Phys Chem B; 2023 Sep; 127(36):7708-7720. PubMed ID: 37665658 [TBL] [Abstract][Full Text] [Related]
10. Mutations in DNA binding domain of p53 impede RSL1D1-p53 interaction to escape from degradation in human colorectal cancer cells. Ding L; Zhao C; Xu Y; Zhang Z; Nie Y; Liao K; Chen Y; Tu B; Zhang X Exp Cell Res; 2022 Aug; 417(1):113211. PubMed ID: 35597299 [TBL] [Abstract][Full Text] [Related]
11. Hot-spot mutants of p53 core domain evince characteristic local structural changes. Wong KB; DeDecker BS; Freund SM; Proctor MR; Bycroft M; Fersht AR Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8438-42. PubMed ID: 10411893 [TBL] [Abstract][Full Text] [Related]
12. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs. Zhao Y; Li Y; Sheng J; Wu F; Li K; Huang R; Wang X; Jiao T; Guan X; Lu Y; Chen X; Luo Z; Zhou Y; Hu H; Liu W; Du B; Miao S; Cai J; Wang L; Zhao H; Ying J; Bi X; Song W J Exp Clin Cancer Res; 2019 Aug; 38(1):379. PubMed ID: 31455383 [TBL] [Abstract][Full Text] [Related]
13. Mutant p53-R273H mediates cancer cell survival and anoikis resistance through AKT-dependent suppression of BCL2-modifying factor (BMF). Tan BS; Tiong KH; Choo HL; Chung FF; Hii LW; Tan SH; Yap IK; Pani S; Khor NT; Wong SF; Rosli R; Cheong SK; Leong CO Cell Death Dis; 2015 Jul; 6(7):e1826. PubMed ID: 26181206 [TBL] [Abstract][Full Text] [Related]
14. Dynamics and Molecular Mechanisms of p53 Transcriptional Activation. Offutt TL; Ieong PU; Demir Ö; Amaro RE Biochemistry; 2018 Nov; 57(46):6528-6537. PubMed ID: 30388364 [TBL] [Abstract][Full Text] [Related]
15. Biophysical characterization of p53 core domain aggregates. Lima I; Navalkar A; Maji SK; Silva JL; de Oliveira GAP; Cino EA Biochem J; 2020 Jan; 477(1):111-120. PubMed ID: 31841126 [TBL] [Abstract][Full Text] [Related]
16. Intrinsic Differences in Backbone Dynamics between Wild Type and DNA-Contact Mutants of the p53 DNA Binding Domain Revealed by Nuclear Magnetic Resonance Spectroscopy. Rasquinha JA; Bej A; Dutta S; Mukherjee S Biochemistry; 2017 Sep; 56(37):4962-4971. PubMed ID: 28836764 [TBL] [Abstract][Full Text] [Related]
18. Dynamic perspectives into the mechanisms of mutation-induced p53-DNA binding loss and inactivation using active perturbation theory: Structural and molecular insights toward the design of potent reactivators in cancer therapy. Olotu FA; Soliman MES J Cell Biochem; 2019 Jan; 120(1):951-966. PubMed ID: 30160791 [TBL] [Abstract][Full Text] [Related]
19. Tumorigenic p53 mutants undergo common structural disruptions including conversion to α-sheet structure. Bromley D; Daggett V Protein Sci; 2020 Sep; 29(9):1983-1999. PubMed ID: 32715544 [TBL] [Abstract][Full Text] [Related]
20. Mutants TP53 p.R273H and p.R273C but not p.R273G enhance cancer cell malignancy. Li J; Yang L; Gaur S; Zhang K; Wu X; Yuan YC; Li H; Hu S; Weng Y; Yen Y Hum Mutat; 2014 May; 35(5):575-84. PubMed ID: 24677579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]